Results 11 to 20 of about 63,047 (307)

Salvage Therapy in Early Relapse of T-Lymphoblastic Leukemia/Lymphoma Using Daratumumab/Nelarabine Combination: Two Consecutive Cases

open access: yesCase Reports in Hematology, 2022
Treatment of early relapses of T lymphoblastic leukemia/lymphoma is often unsuccessful. We tested an experimental regimen containing daratumumab and nelarabine in two young patients with early relapses of T lymphoblastic lymphoma and T-ALL, respectively.
Ingolf Molle   +3 more
doaj   +2 more sources

Cardiac tamponade as an initial atypical presentation of T-cell lymphoblastic lymphoma in a 17-year-old adolescent: a case report [PDF]

open access: yesJournal of Medical Case Reports
Background T-cell lymphoblastic lymphoma is a type of non-Hodgkin’s lymphoma, which usually affects adolescents and young adults. The usual presentation is characterized by B symptoms and adenopathy associated with a mediastinal mass.
Mahamadou Charfo Bacharou   +4 more
doaj   +2 more sources

Comparative prognosis of pediatric lymphoblastic lymphoma: insights from Chinese and international cohorts [PDF]

open access: yesFrontiers in Oncology
ObjectiveThe aim of this research was to characterize the clinical features and histological subtypes of pediatric lymphoblastic lymphoma (LBL) and to assess the clinical prognostic factors for 178 pediatric patients.
Luyao Zhang   +9 more
doaj   +2 more sources

Transformation of Aggressive Non-Hodgkin Lymphoma in Acute Lymphoblastic Leukemia

open access: yesJournal of Interdisciplinary Medicine, 2017
Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma (NHL), representing up to 30 percent of all lymphomas. DLBCL is a fast-growing, aggressive form of NHL, which can appear as a transformation from a less aggressive form
Benedek István   +6 more
doaj   +3 more sources

A case of systemic precursor T-cell lymphoblastic lymphoma presenting with single tooth mobility

open access: yesSAGE Open Medical Case Reports, 2020
Lymphoblastic lymphoma, seen primarily in children or young adults, is a type of non-Hodgkin lymphoma that originates from B or T lymphocyte precursors and rarely occurs in the oral cavity.
Lampros Goutzanis   +4 more
doaj   +2 more sources

Sellar B lymphoblastic lymphoma mimics pituitary apoplexy with newly discovered gene mutations in TP53 and PAX5: A case report

open access: yesFrontiers in Oncology, 2023
Lymphoblastic lymphoma (LBL) is a rare tumor that accounts for approximately 2-4% of all non-Hodgkin lymphomas, and less than 20% of LBLs are derived from B cells.
Yi Wang   +8 more
doaj   +1 more source

Malignant lymphoma, lymphoblastic [PDF]

open access: yesCancer, 1976
Among the malignant lymphomas of the diffuse, poorly differentiated lymphocytic type, a cytologically distinctive form can be recognized. It is composed of immature lymphoid cells that are indistinguishable from the cells of acute lymphoblastic leukemia (ALL).
B N, Nathwani, H, Kim, H, Rappaport
openaire   +2 more sources

Extranodal Biphenotypic Non-Hodgkin Lymphoma of the Popliteal Cavity: A Case Report and Review of Literature

open access: yesDiagnostics, 2022
Primary soft-tissue lymphoma (PSTL) is a rare extranodal non-Hodgkin lymphoma, characterized by a mass growing within soft-tissue, which is connective tissue, adipose tissue, and skeletal muscle.
Giulia A. Restivo   +8 more
doaj   +1 more source

Lymphoblastic lymphoma in adults [PDF]

open access: yesCancer, 1981
Clinical and cytogenetic studied were done on 12 patients with lymphoblastic lymphoma. The ages of the patients ranged from 17 to 58 years (median, 24.5 years). Males predominated by a ration of 5:1. Ten of the 12 patients had a mediastinal mass at diagnosis; two thirds of the patients had involvement of the bone marrow (3 of 12 patients initially were
R A, Streuli   +5 more
openaire   +2 more sources

The chemotherapy of lymphoblastic lymphoma [PDF]

open access: yesBlood, 1981
Abstract Thirty-two patients treated on consecutive Southwest Oncology Group (SWOG) protocols for malignant lymphoma were subsequently diagnosed as having lymphoblastic lymphoma. Combination chemistry, usually adriamycin-based, produced complete responses (CR) in 17 patients (53%). Median survival was 15 mo.
J B, Voakes, S E, Jones, E M, McKelvey
openaire   +3 more sources

Home - About - Disclaimer - Privacy